Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 11,587 | 10,450 | 8,486 | 12,344 | 7,804 |
| Cost of Goods | 11,391 | 9,672 | 9,287 | 6,685 | 6,495 |
| Gross Profit | 196 | 778 | -801 | 5,659 | 1,309 |
| Operating Expenses | 19,232 | 17,279 | 15,192 | 12,970 | 12,941 |
| Operating Income | -18,645 | -15,829 | -15,706 | -6,626 | -11,137 |
| Interest Expense | 1,519 | 343 | 456 | 494 | 514 |
| Other Income | -3,416 | -174 | 417 | -1,176 | -243 |
| Pre-tax Income | -23,580 | -16,346 | -15,745 | -8,296 | -11,894 |
| Income Tax | -442 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -23,138 | -16,346 | -15,745 | -8,296 | -11,894 |
| Net Income | $-23,138 | $-16,346 | $-15,745 | $-8,296 | $-11,894 |
| EPS Basic Total Ops | -0.71 | -0.49 | -0.49 | -0.27 | -0.47 |
| EPS Basic Continuous Ops | -0.71 | -0.50 | -0.49 | -0.27 | -0.47 |
| EPS Diluted Total Ops | -0.71 | -0.49 | -0.49 | -0.27 | -0.47 |
| EPS Diluted Continuous Ops | -0.71 | -0.50 | -0.49 | -0.27 | -0.47 |
| EBITDA(a) | $-16,265 | $-14,184 | $-14,090 | $-5,074 | $-9,710 |